Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevicontrol-2: Olmesartan/Amlodipine vs Candesartan in Hypertension
NCT01611077Phase 4Completed
- Sponsor
- Institut für Pharmakologie und Präventive Medizin
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan medoxomil + amlodipine in hypertension (HTN), sponsored by Institut für Pharmakologie und Präventive Medizin. Started Jan 2012; status: completed.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01611077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611077.